Company profile
CDMO, CMO, Contract Development and Manufacturing Organisation
Contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, provides API and ADC services. Read more...
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
SH01 | Transaction MzUxNDEzMDkzOWFkaXF6a2N4
Published 02 Apr 2026 14:58
Last confirmation statement made up date
Last accounts made up date
MR01 | Transaction MzQ0NDU5OTAxMmFkaXF6a2N4
Published 25 Nov 2024 10:23
MR01 | Transaction MzQ0NDU5OTAyOWFkaXF6a2N4
Published 25 Nov 2024 10:22
MR01 | Transaction MzQ0NDU5OTAxOGFkaXF6a2N4
Published 25 Nov 2024 08:23
MR04 | Transaction MzQzNzY5OTk4OGFkaXF6a2N4
Published 30 Sep 2024 09:49
MR04 | Transaction MzQzNzY5OTQ1M2FkaXF6a2N4
Published 30 Sep 2024 09:46
MR04 | Transaction MzQzNzY5OTIxNmFkaXF6a2N4
Published 30 Sep 2024 09:46
MR04 | Transaction MzQzNzY5ODg5N2FkaXF6a2N4
Published 30 Sep 2024 09:44
Company registered at Companies House
1 Mar 2021 to 29 Feb 2024
Improving working practices by adopting the latest technologies and best approaches into a commercial organisation benefits the company by providing it with a series of competitive edges. In the areas of pharmaceutical, agrochemical and neuroceuticals synthesis, Flow Chemistry based process manufacturing is a new approach that boosts both efficiency and p...
1 Sep 2019 to 31 Aug 2021
To develop a new enzyme discovery workflow (process) exemplified by a novel biocatalytic methodology, which will allow SPSL to expand manufacture for the fine chemicals and pharmaceuticals markets.
1 Jul 2015 to 30 Jun 2016
A consortium comprising Shasun, Prozomix and CatScI has been established as part of the Innovate UK’s IB Catalyst. The key goal of the project is to develop a novel IB route to a nutraceutical that is currently manufactured through traditional chemical manufacturing techniques or isolated from scarce natural resources. The new technology has the potential...
